Wu Heng, Manglike Ayinuer, Chen Yixiao, Liu Ziming, Fritzsche Kurt, Lu Zheng
Department of Psychosomatic Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Department of Psychosomatic Medicine and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
Gen Psychiatr. 2023 Jun 9;36(3):e100942. doi: 10.1136/gpsych-2022-100942. eCollection 2023.
Somatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms. Based on the previous work, this review aims to comprehensively synthesise updated evidence related to SSD from recent years in English publications and, more extensively, from data published in Chinese language journals. The scoping review update was based on an earlier scoping review and included Chinese language publication data from China National Knowledge Internet (CNKI), WANFANG and WEIPU between January 2013 and May 2022 and data from PubMed, PsycINFO, and Cochrane Library between June 2020 and May 2022. Initially, 2 984 articles were identified, of which 63 full texts were included for analysis. In China, SSD is mainly applied in scientific research, but it also shows good predictive validity and clinical application potential. The mean frequency of SSD was 4.5% in the general population, 25.2% in the primary care population and 33.5% in diverse specialised care settings. Biological factors, such as brain region changes and heart rate variability, are associated with the onset of SSD. Psychological impairment related to somatic symptoms is the best predictor of prognosis. While adolescent SSD was significantly associated with family function, SSD overall is associated with an increased dysfunction of cognition and emotion, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Further research is needed on suicide risk and cultural and gender-related issues. Updating the data of Chinese language studies, our research enriches the evidence-based findings related to the topics addressed in the text sections of the SSD chapter of DSM-5. However, research gaps remain about SSD reliability, population-based prevalence, suicide risk, and cultural and gender-related issues.
躯体症状障碍（SSD）是《精神疾病诊断与统计手册》第五版（DSM - 5）中引入的一种新诊断，旨在解决具有医学无法解释症状患者的诊断难题。基于以往的工作，本综述旨在全面综合近年来英文出版物中与SSD相关的最新证据，更广泛地说，还包括中文期刊发表的数据。本次范围综述更新基于早期的范围综述，纳入了2013年1月至2022年5月期间来自中国知网（CNKI）、万方和维普的中文出版物数据，以及2020年6月至2022年5月期间来自PubMed、PsycINFO和考科蓝图书馆的数据。最初，共识别出2984篇文章，其中63篇全文被纳入分析。在中国，SSD主要应用于科研，但也显示出良好的预测效度和临床应用潜力。SSD在普通人群中的平均发生率为4.5%，在初级保健人群中为25.2%，在不同的专科护理环境中为33.5%。生物因素，如脑区变化和心率变异性，与SSD的发病有关。与躯体症状相关的心理损害是预后的最佳预测指标。虽然青少年SSD与家庭功能显著相关，但总体而言，SSD与认知和情绪功能障碍增加、生活质量下降以及焦虑和抑郁障碍的高共病率有关。需要对自杀风险以及文化和性别相关问题进行进一步研究。更新中文研究数据，我们的研究丰富了与DSM - 5中SSD章节文本部分所涉及主题相关的循证研究结果。然而，关于SSD的可靠性、基于人群的患病率、自杀风险以及文化和性别相关问题仍存在研究空白。
Zotero 插件
